Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1523-1530

  Blaser, Martin J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BARRETT ESOPHAGUS; CONFERENCE PAPER; DUODENUM ULCER; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; STOMACH CARCINOMA;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DUODENAL ULCER; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; EVOLUTION; GASTROESOPHAGEAL REFLUX; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MODELS, BIOLOGICAL; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 0033028812     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314785     Document Type: Conference Paper

References (92)

1. 1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-5.
2. 2. Bizzozero G. Gulle ghiandole tubulari del tube gastroenterico e sui rapporti del loro coll'epitelio de rivestimento della mucosa. Atti d R Accad delle Sci di Torino 1892-1893;28:233-51.
3. 3. Nomura A, Stemmerman GN, Chyou PH, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994;120:977-81.
4. 4. Sipponen P, Varis K, Fraki O, Korri UM, Seppaa K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990;25:966-73.
5. 5. International Agency for Research of Cancer. Monographs on the evaluation of carcinogenic risks to humans. Infection with Helicobacter pylori. Lyons, France, 1994;60:177-240.
6. 6. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
7. 7. Graham DY. The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet 1997;350:70-1.
8. 8. Kapur V, Whittam TS, Musser JM. Is Mycobacterium tuberculosis 15,000 years old? J Infect Dis 1994;170:1348-9.
9. 9. Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997;349:1020-2.
10. 10. Blaser MJ. Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era. Gut 1998;43:721-7.
11. 11. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997;100:759-62.
12. 12. Mattsson A, Lonroth H, Quiding-Jarbrink M, Svennerholm AM. Induction of B cell responses in the stomach of Helicobacter pylori infected subjects after oral cholera vaccination. J Clin Invest 1998;102:51-6.
13. 13. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102:720-7.
14. 14. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
15. 15. Kirschner DE, Blaser MJ. The dynamics of Helicobacter pylori infection of the human stomach. J Theor Biol 1995;176:281-90.
16. 16. Crabtree JE, Wyatt JI, Trejdosiewicz LK, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 1994;47:61-6.
17. 17. Lynch DAF, Mapstone NP, Clarke AMT, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995;36:346-50.
18. 18. Logan RH, Berg DE. Genetic diversity of Helicobacter pylori. Lancet 1996;348:1462-3.
19. 19. Meyer-Konig U, Ebert K, Schrage B, Pollak S, Hufert FT. Simultaneous infection of healthy people with multiple human cytomegalovirus strains. Lancet 1998;352:1280-1.
20. 20. Taylor NS, Fox JG, Akopyants NS, et al. Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. J Clin Microbiol 1995;33:918-23.
21. 21. Jorgensen M, Daskalopoulos G, Warburton V, Mitchell HM, Hazell SL. Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens. J Infect Dis 1996;174:631-5.
22. 22. Go MF, Kapur V, Graham DY, Musser JM. Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol 1996;178: 3934-8.
23. 23. Kansau I, Raymond J, Bingen E. Genotyping of Helicobacter pylori isolates by sequencing of PCR products and comparison with the RAPD technique. Res Microbiol 1996;147:661-9.
24. 24. Jiang Q, Hiratsuka K, Taylor DE. Variability of gene order in different Helicobacter pylori strains contributes to genome diversity. Mol Microbiol 1996;20:833-42.
25. 25. Kersulyte D, Akopyants NS, Clifton SW, Roc BA, Berg DE. Novel sequence organization and insertion specificity of IS605 and IS606: chimaeric transposable elements of Helicobacter pylori. Gene 1998;223:175-86.
26. 26. Akopyants NS, Fradkov A, Diatchenko L, et al. PCR-based substractive hybridization and differences in gene content among strains of Helicobacter pylori. Proc Natl Acad Sci USA 1998;95:1-6.
27. 27. Censini S, Lange C, Xiang J, et al. cag, a pathogenicity island of Helicobacter pylori encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996;93:14648-53.
28. 28. Akopyants NS, Clifton SW, Kersulyte D, et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998;28:37-53.
29. 29. Atherton J, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TC. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270:17771-7.
30. 30. Peek RM Jr, Thompson SA, Donahue JP, et al. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians 1998;110:531-44.
31. 31. Weel JFL, Vanderhulst RWM, Gerrits Y, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori related diseases. J Infect Dis 1996;173:1171-5.
32. 32. van Doorn LJ, Figueirdo C, Samnna R, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998;115: 58-66.
33. 33. Cover TL, Dooley CP, Blaser MJ. Characterization and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990;58:603-10.
34. 34. Crabtree JE, Taylor JD, Wyatt JL, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
35. 35. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high molecular weight major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993;61:1799-809.
36. 36. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
37. 37. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995;18:867-76.
38. 38. Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997;388:539-47.
39. 39. Blaser MJ. The interaction of cag' Helicobacter pylori strains with their hosts. In: RH Hunt, GNJ Tytgat, eds. Helicobacter pylori, basic mechanisms to clinical cure 1998. Dordrecht, Netherlands: Kluwer Academic, 1998; 27-32.
40. 40. Pérez-Pérez GI, Bhat N, Gaensbauer J, et al. Country-specific constancy by age in cagA' proportion of Helicobacter pylori infections. Int J Cancer 1997;72:453-6.
41. 41. vanderEnde A, Rauws EAJ, Feller M, Mulder CJJ, Tytgat GNJ, Dankert J. Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology 1996;111:638-47.
42. 42. Figura N, Vindigni C, A Covacci L, et al. cagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance to histological damage. Gut 1998;42:772-8.
43. 43. Pan ZJ, vam der Hulst RWM, Feller M, et al. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 1997;35:1344-7.
44. 44. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Munakata JE, CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol 1998;51:225-8.
45. 45. Blaser MJ, Pérez-Pérez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
46. 46. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
47. 47. Kuipers EJ, Pérez-Pérez GI, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
48. 48. Peek RM, Miller GG, Tham KT, et al. Heightened inflammatory response and cytokine expression to cagA' Helicobacter pylori strains. Lab Invest 1995;73:760-70.
49. 49. Sharma SA, Tummuru MKR, Miller GG, Blaser MJ. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 1995;63:1681-7.
50. 50. Webb P, Crabtree JE, Porman D, Eurogast Study Group. Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. Gastroenterol 1999;116:269-76.
51. 51. Peterson W, Feldman M, Cryer B, Lee E, Perez G, Blaser M. Correlation of H. pylori related CagA with severity of fundic gastritis and gastric secretion. Gastroenterology 1998;114:A258.
52. 52. Sharma SA, Tummuru MKR, Blaser MJ, Kerr LD. Activation of interleukin-8 gene expression by Helicobacter pylori is regulated by transcription factor NF-kB in gastric epithelial cells. J Immunol 1998;160:2401-7.
53. 53. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21.
54. 54. Parsonnet J. Incidence of H. pylori infection. Aliment Pharmacol Ther 1995;9(Suppl 2):45-51.
55. 55. Kosunen TU, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119:29-34.
56. 56. Mendall MA, Goggin PM, Molineaux N, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992;339:896-7.
57. 57. Goodman KJ, Correa P, Aux HJT, et al. Helicobacter pylori in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol 1996;144:290-9.
58. 58. Goodman KJ, Correa P, Tengana HJ, DeLany JP, Collazos T. Transmission of H, pylori infection among siblings in a Colombian village. In: Program and abstracts: Helicobacter pylori: basic mechanisms to clinical cure 1998. Montreal: AxCan Pharma, 1998, poster 31.
59. 59. National Center for Health Statistics. Vital statistics of the United States, 1991, vol 1, natality. Washington, DC: Public Health Service, 1995:(section 1)1-2.
60. 60. US Bureau of the Census. Current population reports, P23-181, households, families and children: a 30-year perspective. Washington, DC: US Government Printing Office, 1992:14.
61. 61. US Bureau of the Census. Historical statistics of the United States, colonial times to 1970. Bicentennial Edition, Washington, DC: 1975:(series A288-319)41.
62. 62. Bongaarts J. Demographic consequences of declining fertility. Science 1998;282:419-20.
63. 63. Nyquist AC, Gonzalez R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections and bronchitis. JAMA 1998;279:875-7.
64. 64. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-9.
65. 65. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 1993;88:1860-4.
66. 66. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278:901-4.
67. 67. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995;55:562-5.
68. 68. Hsieh C, Tzonou A, Zavitsanos X, Kaklamani E, Lan S, Trichopoulos D. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. Am J Epidemiol 1992;136:1115-21.
69. 69. Nesse RM, Williams GC. Evolution and the origins of disease. Sci Am 1998;279:86-93.
70. 70. Lee A, Mellgard B, Larsson H. Effect of gastric acid on Helicobacter pylori ecology. In: RH Hunt, Tytgat GNJ, eds. Helicobacter pylori: basic mechanisms to clinical cure 1996. Dordrecht, Netherlands; Kluwer, 1996:50-63.
71. 71. Howson C, Hiyama T, Wynder E. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
72. 72. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
73. 73. Hansen S, Wiig JN, Giercksky KE, Tretli S. Esophageal and gastric carcinoma in Norway, 1958-1972: incidence time trend variability according to morphological subtypes and organ subtypes. Int J Cancer 1997;71: 340-4.
74. 74. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
75. 75. Devesa SS, Blot WJ, Fraumeni JR. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83: 2049-53.
76. 76. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71.
77. 77. Williamson WA, Ellis FH Jr, Gibb SP, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151:2212-6.
78. 78. Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155-8.
79. 79. van Sandick JW, van Lanschot JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Oberlop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-22.
80. 80. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327-33.
81. 81. Prach AT, MacDonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett's oesophagus education, enthusiasm, or epidemiology. Lancet 1997;350:933.
82. 82. Kang JY, Tay HH, Yap I, Guan R, Lim KP, Math MV. Low frequency of endoscopic esophagitis in Asian patients. J Clin Gastroenterol 1993;16: 70-3.
83. 83. Werdmuller BFM, Loffeld RJLF. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997;42:103-5.
84. 84. Varanasi RV, Fantry GT, Wilson KT. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1998;3: 188-94.
85. 85. Vicari JJ, Peek RM, Falk GW, et al. The scroprevalence of cagA positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
86. 86. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MKR, Pérez-Pérez, GI. The high molecular weight CagA protein as a marker for ulcerogenic strains of Helicobacter pylori. J Clin Microbiol 1995;33:1496-500.
87. 87. Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
88. 88. Hansen S, Vollset SE, Ardill JES, et al. Hypergastrineamia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons. Gut 1997;(suppl 1):A45,04/162.
89. 89. Karita M, Blaser MJ. Acid tolerance response in Helicobacter pylori and differences between cagA' and cagA strains. J Infect Dis 1998;178:213-9.
90. 90. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA' strains of Helicobacter pylori infection and risk esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90.
91. 91. Bayerdorffer E, Lehn N, Hatz R, et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992;102: 1575-82.
92. 92. Mackowiak P. The normal microbial flora. N Engl J Med 1982;307:83-93.